Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 313015, 6 pages
http://dx.doi.org/10.1155/2014/313015
Research Article

Oxidative Stress Indicators in Patients with Prostate Disorders in Enugu, South-East Nigeria

1Department of Chemical Pathology, University of Nigeria Teaching Hospital, Ituku/Ozalla, Enugu state 400001, Nigeria
2Department of Biochemistry, University of Nigeria, Nsukka, Enugu State 400001, Nigeria
3Department of Human Biochemistry, Nnamdi Azikiwe University, Awka, Anambra State 400001, Nigeria

Received 8 February 2014; Revised 2 April 2014; Accepted 7 April 2014; Published 24 April 2014

Academic Editor: Sue-Hwa Lin

Copyright © 2014 Romanda Duru et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. O. Awodele, A. A. Adeyomoye, D. F. Awodele, V. B. Fayankinnu, and D. C. Dolapo, “Cancer distribution pattern in south-western Nigeria,” Tanzania Journal of Health Research, vol. 13, no. 2, pp. 106–108, 2011. View at Google Scholar · View at Scopus
  2. American Cancer Society, Cancer Facts & Figures 2013, American Cancer Society, Atlanta, Ga, USA, 2013.
  3. P. Gomez, “Opening Session of the Second Biennial Science of Global Prostate Cancer Disparities in Black Men Conference,” Bahamas Information Services Updates, 2012, http://www.thebahamasweekly.com.
  4. A. O. Kolawole, “Feasible cancer control strategies for Nigeria: mini-review,” American Journal of Tropical Medicine & Public Health, vol. 1, no. 1, pp. 1–10, 2011. View at Google Scholar
  5. A. Alcaraz, P. Hammerer, A. Tubaro, F. H. Schröder, and R. Castro, “Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review,” European Urology, vol. 55, no. 4, pp. 864–875, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. D. G. Bostwick, H. B. Burke, D. Djakiew et al., “Human prostate cancer risk factors,” Cancer, vol. 101, no. 10, pp. 2371–2490, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. M. M. Shen and C. Abate-Shen, “Molecular genetics of prostate cancer: new prospects for old challenges,” Genes and Development, vol. 24, no. 18, pp. 1967–2000, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Finkel, “Signal transduction by reactive oxygen species,” Journal of Cell Biology, vol. 194, no. 1, pp. 7–15, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. Q. Shazia, Z. H. Mohammad, T. Rahman, and H. U. Shekhar, “Correlation of oxidative stress with serum trace element levels and antioxidant enzyme status in beta thalassemia major patients: a review of the literature,” Anemia, vol. 2012, Article ID 270923, 7 pages, 2012. View at Publisher · View at Google Scholar
  10. M. M. Elahi, Y. X. Kong, and B. M. Matata, “Oxidative stress as a mediator of cardiovascular disease,” Oxidative Medicine and Cellular Longevity, vol. 2, no. 5, pp. 259–269, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Woźniak, R. Masiak, M. Szpinda et al., “Oxidative stress markers in prostate cancer patients after HDR brachytherapy combined with external beam radiation,” Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 789870, 5 pages, 2012. View at Publisher · View at Google Scholar
  12. D. A. Frohlich, M. T. McCabe, R. S. Arnold, and M. L. Day, “The role of Nrf2 in increased reactive oxygen species and DNA damage in prostate tumorigenesis,” Oncogene, vol. 27, no. 31, pp. 4353–4362, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. V. Lobo, A. Patil, A. Phatak, and N. Chandra, “Free radicals, antioxidants and functional foods: impact on human health,” Pharmacognosy Reviews, vol. 4, no. 8, pp. 118–126, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Johnson and C. Giulivi, “Superoxide dismutases and their impact upon human health,” Molecular Aspects of Medicine, vol. 26, no. 4-5, pp. 340–352, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Abe, W. Xie, M. M. Regan et al., “Single-nucleotide polymorphisms within the antioxidant defence system and associations with aggressive prostate cancer,” British Journal of Urology, vol. 107, no. 1, pp. 126–134, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. F. L. Muller, W. Song, Y. Liu et al., “Absence of CuZn superoxide dismutase leads to elevated oxidative stress and acceleration of age-dependent skeletal muscle atrophy,” Free Radical Biology and Medicine, vol. 40, no. 11, pp. 1993–2004, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. K. S. Adedapo, O. G. Arinola, O. B. Shittu, O. I. Kareem, C. A. Okolo, and L. N. Nwobi, “Diagnostic value of lipids, total antioxidants, and trace metals in benign prostate hyperplasia and prostate cancer,” Nigerian Journal of Clinical Practice, vol. 15, no. 3, pp. 293–297, 2012. View at Publisher · View at Google Scholar
  18. L. I. Stowell, L. E. Sharman, and K. Hamel, “An enzyme-linked immunosorbent assay (ELISA) for prostate-specific antigen,” Forensic Science International, vol. 50, no. 1, pp. 125–138, 1991. View at Publisher · View at Google Scholar · View at Scopus
  19. D. E. Paglia and W. N. Valentine, “Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase,” The Journal of Laboratory and Clinical Medicine, vol. 70, no. 1, pp. 158–169, 1967. View at Google Scholar · View at Scopus
  20. H. Ukeda, S. Maeda, T. Ishii, and M. Sawamura, “Spectrophotometric assay for superoxide dismutase based on tetrazolium salt 3′-{1-[(phenylamino)-carbonyl]-3,4-tetrazolium}-bis(4-methoxy-6- nitro)benzenesulfonic acid hydrate reduction by xanthine-xanthine oxidase,” Analytical Biochemistry, vol. 251, no. 2, pp. 206–209, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. H. V. Nino and W. Shah, “Vitamins,” in Fundamentals of Clinical Chemistry, N. W. Tietz, Ed., pp. 547–550, WB Saunders, Philadelphia, Pa, USA, 2nd edition, 1986. View at Google Scholar
  22. J. Fabianek, J. DeFilippi, T. Richards, and A. Herp, “Micromethod for tocopherol determination in blood serum,” Clinical Chemistry, vol. 14, no. 5, pp. 456–462, 1968. View at Google Scholar · View at Scopus
  23. O. Akinloye, O. Adaramoye, and O. Kareem, “Changes in antioxidant status and lipid peroxidation in Nigerian patients with prostate carcinoma,” Polskie Archiwum Medycyny Wewnetrznej, vol. 119, no. 9, pp. 526–532, 2009. View at Google Scholar · View at Scopus
  24. M. I. Yilmaz, K. Saglam, A. Sonmez et al., “Antioxidant system activation in prostate cancer,” Biological Trace Element Research, vol. 98, no. 1, pp. 13–19, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Sandhya, S. Manoharan, G. S. Lavanya, and C. R. Manmohan, “Lipid peroxidation and antioxidant status in prostate cancer patients,” Indian Journal of Science and Technology, vol. 3, no. 1, pp. 83–86, 2010. View at Google Scholar
  26. G. Barrera, S. Pizzimenti, and M. U. Dianzani, “Lipid peroxidation: control of cell proliferation, cell differentiation and cell death,” Molecular Aspects of Medicine, vol. 29, no. 1-2, pp. 1–8, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Aydin, Z. Arsova-Sarafinovska, A. Sayal et al., “Oxidative stress and antioxidant status in non-metastatic prostate cancer and benign prostatic hyperplasia,” Clinical Biochemistry, vol. 39, no. 2, pp. 176–179, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Kotrikadze, M. Alibegashvili, M. Zibribadze et al., “Activity and content of antioxidant enzymes in prostate tumors,” Experimental Oncology, vol. 30, no. 3, pp. 244–247, 2008. View at Google Scholar · View at Scopus
  29. C.-C. Yeh, M.-F. Hou, S.-M. Tsai et al., “Superoxide anion radical, lipid peroxides and antioxidant status in the blood of patients with breast cancer,” Clinica Chimica Acta, vol. 361, no. 1-2, pp. 104–111, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. K. M. Surapaneni and G. R. Venkata, “Lipid peroxidation and antioxidant status in patients with carcinoma of prostate,” Indian Journal of Physiology and Pharmacology, vol. 50, no. 4, pp. 350–354, 2006. View at Google Scholar · View at Scopus
  31. V. Battisti, L. D. K. Maders, M. D. Bagatini et al., “Oxidative stress and antioxidant status in prostate cancer patients: relation to Gleason score, treatment and bone metastasis,” Biomedicine and Pharmacotherapy, vol. 65, no. 7, pp. 516–524, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. D. S. L. Srivastava and R. D. Mittal, “Free radical injury and antioxidant status in patients with benign prostate hyperplasia and prostate cancer,” Indian Journal of Clinical Biochemistry, vol. 20, no. 2, pp. 162–165, 2005. View at Google Scholar · View at Scopus